Wisconsin

Wisconsin

NO
Registered Patient Population		 0%
of Total Population Represented by Patients		 0
Total Medical Retail Locations Currently in Operation		 N/A
Ratio of Patients to Retail Location

CBD treatment is legal in Wisconsin. The program limits patients to cannabidiol preparations with 0.3 percent or less THC, in compliance with USDA hemp standards and authorizes in-state production according to those rules.

Patient Rights and Civil Protection 34/100   
Arrest Protection 20/40
Affirmative Defense 9/15
Parental Rights Protections 0/10
DUI Protections 0/5
Employment Protections 0/5
Explicit Privacy Standards 0/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 5/5
Organ Transplants 0/5
Reciprocity 0/3
Access to Medicine 13/100   
Allows Distribution Programs 0/40
– Allows Access to Dried Flowers 0/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 0/5
– Allows for a Reasonable Number of Dispensaries 0/5
– Does Not Require Vertical Integration 0/2
– Ownership/Employment Restrictions 0/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 0/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 3/10
Does not Impose Bans or Limits on THC 0/10
Does not Impose Bans on CBD 10/10
Local Bans/Zoning 0/10
Ease of Navigation 40/100   
Comprehensive Qualifying Conditions 20/50
Adding New Conditions 0/10
– Law/Regulations Allow for New Conditions 0/5
– System Works for Adding New Conditions 0/5
Reasonable Access for Minors 6/10
Reasonable Caregiver Background Checks 0/4
Number of Caregivers 0/2
Patient/ Practitioner- Focused Task Force or Advisory Board 0/2
Reasonable Fees (Patients and Caregivers) 6/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 3/5
Functionality 20/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 0/50
No Significant Administrative or Supply Problems 0/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 10/10
Reasonable Possession Limits 5/5
Reasonable Purchase Limits 0/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 2/7
Consumer Safety and Provider Requirements 0/100   
Dispensing 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility Sanitary Conditions 0/1.25
– Storage Protocols 0/1.25
– Reasonable Security Protocols 0/1.25
– Inventory Control 0/1.25
Recall Protocol and Adverse Event Reporting 0/5
Product Labeling 0/5
– Product Contents, Including Source Material Identification 0/1.67
– Allergens 0/1.67
– Potency/Compound Identification 0/1.67
Required Testing 0/5
– Active Compound Identification 0/1.67
– Contaminants 0/1.67
– Potency 0/1.67
Grow/Cultivation 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0/0.71
– Reasonable Security Protocols 0/0.71
– Batch and Lot Tracking 0/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 0/5
– Pesticide Guidance 0/2.5
– Pesticide Labeling 0/2.5
Required Testing 0/5
– Active Ingredient Identification 0/1.25
– Contaminants 0/1.25
– Potency 0/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 0/5
Manufacturing 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/1
– Workforce Safety Protocols 0/1
– Storage Protocols 0/1
– Reasonable Security Protocols 0/1
– Batch and Lot Tracking 0/1
Product Labeling 0/5
– Product Contents, Including Source Material Identification 0/1.67
– Allergens 0/1.67
– Potency and Compound Information 0/1.67
Required Testing 0/5
– Active Ingredient Identification 0/1
– Contaminants 0/1
– Potency 0/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 0/5
Laboratory Operations 0/25
Staff Training 0/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 0/5
Independent or Third Party 0/5
Standard Operating Procedures and Protocols 0/5
– Equipment and Instrument Calibration 0/0.83
– Sample Tracking 0/0.83
– Facility and Equipment Sanitary Conditions 0/0.83
– Disposal/Waste 0/0.83
– Storage Protocols 0/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 0/20   
Delivery Available? 0/6
Curbside Pickup Available? 0/2
Medical Cannabis Essential? 0/7
Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

Wisconsin Medical Marijuana Laws and Regulations

headline

Wisconsin’s first medical marijuana law took effect in 2014, protecting an extremely narrow class of people. Otherwise known as a CBD-only bill, patients must be diagnosed with a seizure disorder to receive legal protection and may not possess cannabis that can produce psychoactive effects. In 2017, the CBD-only program was opened up to any patient with any medical condition.

Becoming a Patient in Wisconsin

headline

In order to become a medical cannabis patient in Wisconsin, a person must obtain official documentation from their physician which states that they have been diagnosed with a seizure disorder. A doctor’s authorization allows the patient to use and possess only forms of cannabis which do not produce a psychoactive effect. Although precise concentration of cannabidiol is not specified under Wisconsin law, it is generally understood that cannabis containing less than 0.03% THC will not produce a psychoactive effect. Wisconsin’s limited-use law does not apply to those who suffer from other debilitating medical conditions, such as cancer or Multiple Sclerosis, nor patients whose doctors advise them to use higher THC:CBD ratios.

Recommending Cannabis in Wisconsin

headline

In Wisconsin, physicians may obtain an investigational drug permit to dispense cannabidiol in non-psychoactive forms. Alternatively, physicians can provide a patient with official documentation that states that the individual is authorized to possess non-psychoactive forms of cannabis to treat a seizure disorder.

Becoming a Caregiver, Producer, or Provider in Wisconsin

headline

Caregivers, cultivators, and providers are not covered in Wisconsin's current law.

Wisconsin Advocacy

headline

Find local ASA Chapters, Action Groups and Affiliates in Wisconsin and get involved in local campaigns.

The State of Medical Marijuana in Wisconsin

headline

The State of Medical Marijuana in Wisconsin

In This Section

Resources

COVID-19 Response Members Only Take Action Now! Chapters & Groups Spread the Word! Events

State Advocacy Resources

Local Resources Nationwide
Donate

Brought To You By

ASA Members

 Place your Ad Here!

Sign In

Sign in with Facebook Sign in with Twitter Sign in with Email
Follow @SafeAccess
Become A Member of Americans for Safe Access Today!